Benzinga's Top #PreMarket Gainers

By: via Benzinga
Intercept Pharmaceuticals (NASDAQ: ICPT) shares surged 56.11% to $370.25 in pre-market trading following the release of the company's Q2 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.